3Raizer J J, Rademaker A, Evens AM, et al. Pemetrexed in the treatment o{ relapsed/refractory primary central nerv ous system lymphoma[J]. Cancer, 2012,118 (15) : 3743- 3748. 被引量：1
5Ilica AT,Kocacelebi K,Savas R,et al. Imaging of extranodal lym- phoma with PET/CT[J]. Clin Nucl Med, 2011,36 (10): e127 e138. 被引量：1
6Schaefer NG, Hany TF, Taverna C, et al. Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging-do we need contrast- enhanced CT? [J]. Radiology, 2004,232(3) :823-829. 被引量：1
7Schae{er NG,Strobel K,Taverna C,et al. Bone involvement in pa- tients with lymphoma= the role of FDG-PET/CT[J]. Eur J Nucl Med Mol Imaging,2007,34(1) :60- 67. 被引量：1
8Pakos EE,Fotopoulos AD,Ioannidis JP,et al. 18F-FDG PET for e- valuation of bone marrow infiltration in staging of lymphoma= a meta-analysis[J]. J Nucl Med,2005,46(6) :958-963. 被引量：1
